Raymond James Financial
IRWD icon

Raymond James Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Raymond James Financial’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.05M Sell
725,085
-38,870
-5% -$150K ﹤0.01% 3166
2026
Q1 		$2.68M Sell
763,955
-105,871
-12% -$434K ﹤0.01% 3111
2025
Q4 		$2.93M Buy
869,826
+854,780
+5,681% +$2.22M ﹤0.01% 2946
2025
Q3 		$19.7K Sell
15,046
-249
-2% -$258 ﹤0.01% 4906
2025
Q2 		$11K Hold
15,295
– – ﹤0.01% 5889
2025
Q1 		$22.5K Hold
15,295
– – ﹤0.01% 4708
2024
Q4 		$67.8K Buy
+15,295
New +$62.1K ﹤0.01% 4569

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Raymond James Financial's IRWD Position: Q2 2026 in Review

Raymond James Financial reduced its Ironwood Pharmaceuticals (IRWD) stake by 5.1% in Q2 2026, selling an estimated $150K and leaving 725,085 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3166.

Raymond James Financial first reported a position in IRWD in Q4 2024 and has held it in 7 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Raymond James Financial held 725,085 shares of Ironwood Pharmaceuticals worth $3.05M as of Q2 2026.
  • Raymond James Financial sold 38,870 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $150K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3166 holding.
  • Raymond James Financial first reported a position in Ironwood Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.